Utilization of Complementary and Alternative Therapies in Youth with Developmental Disabilities

Table 3

Summary of hierarchical logistic regression analyses for variables predicting CAM use.

Variable	β	SE B	Wald	OR	95% CI OR
Chelation Use
ASD	3.65	.02	56591.40	38.34	37.21-39.51
CP	-13.84	79.48	.03	.00	- - - -
DS	-15.78	119.64	.02	.00	- - - -
ID	-.30	.02	257.26	.74	.71-.77
DD	.67	.02	2060.05	1.94	1.89-2.00
Vitamin/Mineral Use
ASD	.14	.003	2352.50	1.15	1.14-1.15
CP	.26	.006	1964.42	1.29	1.28-1.31
DS	.88	.01	6714.58	2.41	2.36-2.46
ID	-.19	.003	4716.94	.83	.82-.83
DD	.17	.002	12713.32	1.19	1.18-1.19
Specific Vitamin Use^1
ASD	.19	.003	2979.92	1.21	1.20-1.22
CP	-.29	.008	1274.06	.75	.74-.76
DS	1.38	.009	26233.91	3.99	3.93-4.06
ID	.11	.004	941.98	1.12	1.11-1.13
DD	.20	.002	11407.47	1.23	1.22-1.23
Mg, Fe, Cr, Zn, Se, or K Use
ASD	.35	.004	8679.72	1.41	1.41-1.43
CP	.37	.007	2603.43	1.45	1.43-1.47
DS	.33	.01	733.54	1.39	1.35-1.42
ID	.08	.004	320.99	1.08	1.07-1.09
DD	.75	.002	130114.47	2.11	2.10-2.12
Herbal or Non-Vitamin Supplement Use
ASD	.42	.004	12471.64	1.52	1.51-1.53
CP	-.10	.009	113.00	.91	.89-.92
DS	1.48	.01	19563.34	4.38	4.29-4.48
ID	-.77	.006	19245.58	.46	.46-.47
DD	.98	.002	222831.17	2.67	2.66-2.68
Combination Herb Pill Use
ASD	1.74	.01	20711.72	5.73	5.60-5.87
CP	3.01	.02	25373.85	20.20	19.46-20.96
DS	-16.97	278.99	.004	.00	- - - -
ID	-17.97	195.43	.008	.00	- - - -
DD	1.07	.009	15119.70	2.91	2.86-2.95

p<.001; Mg=magnesium; Fe= iron; Cr= chromium; Zn=zinc; Se=selenium; K=potassium.
¹Vitamin A, B, C, D, E, H, or K use.